Concepedia

Publication | Open Access

Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement

DOIFull Paper Access

80

Citations

32

References

2012

Year

Pierre‐Yves Salaün, L. Campion, Claire Bournaud, Alain Faivre-Chauvet, Jean‐Philippe Vuillez, David Taïeb, C. Ansquer, Caroline Rousseau, Françoise Borson‐Chazot, Stéphane Bardet,
Journal of Nuclear Medicine

Abstract

pRAIT showed antitumor activity, with manageable hematologic toxicity in progressive MTC. Increased biomarker DT after treatment correlated with increased OS.

References

YearCitations

Page 1